The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies

被引:12
|
作者
Calik, Sebnem [1 ]
Ari, Alpay [1 ]
Bilgir, Oktay [2 ]
Cetintepe, Tugba [2 ]
Yis, Reyhan [3 ]
Sonmez, Ufuk [1 ]
Tosun, Selma [1 ]
机构
[1] Univ Hlth Sci, Izmir Bozyaka Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Izmir, Turkey
[2] Univ Hlth Sci, Dept Hematol, Izmir, Turkey
[3] Univ Hlth Sci, Dept Microbiol & Clin Microbiol, Izmir, Turkey
关键词
BLOOD-STREAM INFECTIONS; CANCER; MANAGEMENT; FEVER; EPIDEMIOLOGY; COMBINATION; GUIDELINES; AMIKACIN; THERAPY; TRIAL;
D O I
10.15537/smj.2018.9.22824
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To determine effective risk factors on mortality in febrile neutropenic cases with hematologic malignancy. Patients with hematologic diseases are more prone to infections and those are frequent causes of mortality. Methods: This retrospective study was performed using data of 164 febrile neutropenic cases with hematologic malignancies who were followed up in a hematology clinic of a tertiary health care center between 2011-2015. The relationship between descriptive and clinical parameters rates and rates of mortality on the 7th and the 21st days were investigated. Results: Patients with absolute neutrophil count<100/mm(3), duration of neutropenia longer than 7 days, pneumonia or gastrointestinal foci of infection, central catheterization (p=0.025), isolation of Gram (-) bacteria in culture, carbapenem resistance, septic shock, and bacterial growth during intravenous administration of antibiotic treatment were under more risk for mortality on both the 7th and the 21st days. The final multivariate logistic regression results showed that pneumonia (p<0.0001), septic shock (p=0.004) and isolation of Gram-negative bacteria (p=0.032) were statistically significant risk factors. Conclusion: Early diagnosis and appropriate treatment of serious infections, which are important causes of morbidity and mortality, are crucial in patients with febrile neutropenia. Thus, each center should closely follow up causes of infection and establish their empirical antibiotherapy protocols to accomplish better results in the management of febrile neutropenia.
引用
收藏
页码:878 / 885
页数:8
相关论文
共 50 条
  • [21] Infections of febrile neutropenic patients in malignant hematological diseases
    Rókusz, L
    Liptay, L
    MILITARY MEDICINE, 2003, 168 (05) : 355 - 359
  • [22] PHARMACOKINETICS OF IMIPENEM CILASTATIN IN NEUTROPENIC PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
    JANMOHAMED, RMI
    LEYLAND, MJ
    KELLY, J
    FARRELL, I
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 (03) : 407 - 412
  • [23] The Relationship Between Hematological Parameters and Mortality in Cardiovascular Patients With Postcardiac Arrest Syndrome
    Erol, Mehmet K.
    Kankilic, Nazim
    Kaya, Firdevs
    Atlas, Ahmet
    Pehlivan, Veli Fahri
    Pehlivan, Basak
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (12)
  • [24] Antifungal prophylaxis with micafungin in neutropenic patients with hematological malignancies
    Hirata, Yuji
    Yokote, Taiji
    Kobayashi, Kichinosuke
    Nakayama, Shoko
    Oka, Satoko
    Miyoshi, Takuji
    Akioka, Toshikazu
    Hiraoka, Nobuya
    Iwaki, Kazuki
    Takayama, Ayami
    Nishimura, Yasuichiro
    Makino, Junko
    Takubo, Takayuki
    Tsuji, Motomu
    Hanafusa, Toshiaki
    LEUKEMIA & LYMPHOMA, 2010, 51 (05) : 853 - 859
  • [25] INTERVENTIONAL ANTIMICROBIAL STRATEGY IN FEBRILE NEUTROPENIC PATIENTS - RESULTS OF A MULTICENTER STUDY IN 1,260 PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
    MASCHMEYER, G
    LINK, H
    HIDDEMANN, W
    MEYER, P
    HELMERKING, M
    ADAM, D
    ONKOLOGIE, 1990, 13 (01): : 38 - 42
  • [26] AMIKACIN IN THE TREATMENT OF FEBRILE COMPLICATIONS OCCURRING DURING THE NEUTROPENIC PHASE OF ACUTE HEMATOLOGICAL MALIGNANCIES
    FIERE, D
    VUVAN, H
    ESPINOUSE, D
    REYNAUD, J
    COIFFIER, B
    FELMAN, P
    VIALARD, L
    NOUVELLE PRESSE MEDICALE, 1979, 8 (42): : 3469 - 3471
  • [27] Altered Pharmacokinetics of Piperacillin in Febrile Neutropenic Patients with Hematological Malignancy
    Sime, Fekade Bruck
    Roberts, Michael S.
    Warner, Morgyn S.
    Hahn, Uwe
    Robertson, Thomas A.
    Yeend, Sue
    Phay, Andy
    Lehman, Sheila
    Lipman, Jeffrey
    Peake, Sandra L.
    Roberts, Jason A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (06) : 3533 - 3537
  • [28] Septifast PCR for the microbiological documentation of infections in febrile neutropenic patients
    Lamoth, Frederic
    Jaton-Ogay, Katia
    Calandra, Thierry
    Prodhom, Guy
    Senn, Laurence
    Bille, Jacques
    Marchetti, Oscar
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : S31 - S32
  • [29] Microbiological profiles and prognostic factors of infection mortality in febrile neutropenic children with malignancy
    Astria, Yuni
    Satari, Hindra Irawan
    Sjakti, Hikari Ambara
    Gunardi, Hartono
    PAEDIATRICA INDONESIANA, 2021, 61 (05) : 283 - 290
  • [30] Evaluation of pulmonary infiltrate in febrile neutropenic patients of hematologic malignancies
    Das, Chandan K.
    Gogia, Ajay
    Kumar, Lalit
    Sharma, Atul
    Thulkar, Sanjay
    Xess, Immaculata
    Madan, Karan
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2019, 40 (03) : 386 - 390